cedar pollinosis or mite antigen induced allergic rhinitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Common to Both Group 1)Patients with cedar pollen allergy and/or mite allergic rhinitis whose target period includes the start of SLIT and 6 months after the start Telemedicine Group 1)Patients who have had at least one telemedicine within 6 months after the start of SLIT In-person care Group 1)Patients who have never had telemedicine and only have had in-person care within 6 months after the start of SLIT
Exclusion criteria
Exclusion criteria: Common to Both Group 1)Patients who reject to be included this study In-person care Group 1)Patients who start SLIT after the telemedicine system introduction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drop-out rate at 6 months after the start of SLIT | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects Continuation rate for treatment Cost burden of patient Treatment effectivity | — |
Countries
Japan
Contacts
Yokohama City University School of Medicine Department of Medial Education